EIB supports pharma innovator

  • 0

The European Investment Bank (EIB) is providing a €45 million loan to part-finance HIPRA's investments, working capital requirements and research, development and innovation activities for developing a new COVID-19 vaccine

Blurred image of Trade Finance article content